Crinetics Pharmaceuticals (CRNX) Price-to-Earnings (P/E) Ratio
Price: $25.56
Market Cap: $2.38B
Avg Volume: 1.10M
Market Cap: $2.38B
Avg Volume: 1.10M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Crinetics Pharmaceuticals's P/E ratios across different time periods:
- TTM: -7.84
- Annual: -13.84
- Quarterly: -14.51
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 3.12
- Price-to-Sales (P/S) Ratio: 3975.39
Annual Ratios
Crinetics Pharmaceuticals Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
-7.84
P/B Ratio (Annual)
3.12
P/S Ratio (Annual)
3975.39
Crinetics Pharmaceuticals Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | -13.84 | 3.12 | 3975.39 |
| 2023 | -9.63 | 3.83 | 514.87 |
| 2022 | -5.95 | -2.17 | 200.82 |
| 2021 | -10.23 | -3.97 | 1012.96 |
| 2020 | -5.90 | -2.56 | 6051.00 |
| 2019 | -12.24 | -6.47 | 508.42 |
| 2018 | -13.43 | -8.39 | 149.97 |
| 2017 | -37.15 | -22.64 | 166.33 |
| 2016 | -56.51 | -54.83 | 577.51 |
Related Metrics
Explore detailed financial metrics and analysis for CRNX.